An observational cohort study of the risk of thromboembolic events among adult patients treated with KCENTRA® compared with plasma for urgent reversal of vitamin K antagonist therapy in the setting of acute major bleeding (REVERSAL)

10/03/2015
23/04/2024
EU PAS number:
EUPAS8472
Study
Finalised

ENCePP Code of conduct

No
Data sources

Data source(s), other

KPNC and KPSC Virtual Data Warehouse United States

Data sources (types)

Administrative healthcare records (e.g., claims)
Other

Data sources (types), other

Prospective patient-based data collection
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

No